Pharmacogenomic Testing for Clinical Trials

PGx Testing with Unmatched Support

Our dedicated clinical trial team has the expertise and flexibility to help you determine cohort inclusion with
the fastest available turnaround time. We provide direct guidance and assistance throughout all phases of
the trial for continuous support. Testing services include most tier 1 and 2 alleles as classified by the
Association for Molecular Pathology Clinical Practice Committee’s Pharmacogenomics (PGx) Working Group
including specific identification of CYP2D6 copy number variation.

1-Two day turnaround PGx Icons-01

Industry-leading 2 business day turnaround time available

2-Service and SupportPGx Icons-02

Unrivaled service and support

3-Project Manager PGx Icons-03

Dedicated project manager and lab support team

4-Contracts PGx Icons-04

Quick turnaround on quotes and contracts

Laboratory Excellence

We pride ourselves on outstanding patient care, lab safety, and lab operations.

  • CAP and COLA Accredited
  • CLIA certified
  • Results can be provided via email or FTP

Test Menu

Our core test menu includes the following genes:

  • APOE
  • CYP2B6
  • CYP2C8
  • CYP2C9
  • CYP2C19
  • CYP2D6
  • CYP3A4
  • CYP3A5
  • VKORC1

In addition to the genes above, we’re proud to offer LDTs and can custom build panels to fit the needs of
your trial.

Precision medicine is the future for drug development

SDxLabs provides pharmacogenomic testing for pharmaceutical companies and CRO’s to support clinical trials for therapies that are dependent on the CYP450 enzymes for their metabolization.  Our PGx testing helps your trial avoid drug-gene interactions to ensure patient safety, allowing for healthy patient cohorts that can safely metabolize the therapy. Our team has over 20 years of experience providing genetic testing, guiding clinical trials, developing assays, and designing research studies. We know how important it is to provide results quickly and accurately to keep trials moving forward while minimizing costs. SDxLabs offers best-in-class service and support with turnaround times that meet even the most demanding project needs.

We provide support for all phases of your clinical trial to help you safely determine patient eligibility and stratification.

Precision Medicine_166977221

Meet your personal clinical trial management team


Annie Shaw, Lab Supervisor

Annie has over 13 years’ experience managing clinical laboratories.  Her responsibilities include processing tests, data analytics, and lab quality control. Annie previously worked at the Magee-Womens Research Institute, leading execution on high-profile genetic testing projects and working directly with Dr. Peters to conduct and publish research.


Dr. Dave Peters, PhD, Chief Science Officer

Dr. David Peters has over three decades of experience in genetic testing, conducting research studies, and working on clinical trials. Dr. Peters has been a leader and innovator in genetics since he took a position at the University of Pittsburgh in 1995. Dr. Peters continues to drive innovation at the University of Pittsburgh, the Magee-Womens Research Institute, and as the Chief Science Officer at SignatureDx.


Dan Doherty, Lead Clinical Trial Project Manager

Dan has managed hundreds of genetics related clinical trials since 2006, previously working with Genelex and Invitae. Dan brings a depth of knowledge in clinical phenotyping, drug/gene interactions, drug/drug interactions at the enzyme level, and has supported both patients and physicians in the rare disease space for years. 


Want to talk about your clinical trial? Let’s chat.